Introduction

45
Apoptosis induced during influenza virus infection is a major contributing factor to cell 46 death and tissue damage (3, 12, 14, 22, 34) . Studies with the 1918 pandemic virus in macaques 47 showed that activation of the apoptotic pathway was a source of tissue damage during infection 48 (2, 4).
49
Apoptosis, or programmed cell death, is an important cellular signaling response often 50 observed after viral infections. Apoptosis is the process whereby individual cells undergo 51 regulated self-destruction in response to a variety of stimuli. In mammalian cells, the apoptotic 52 pathway can be divided into two signaling cascades: the extrinsic and the intrinsic apoptotic 53 pathways (9). Induction of the extrinsic apoptotic pathway involves the stimulation of death 54 receptors belonging to the tumor necrosis factor receptor (TNFR) family, such as Fas and the 55 tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) (9). The intrinsic 56 apoptotic pathway acts through the mitochondria upon activation, and this signaling process is 57 highly regulated by the Bcl-2 family of proteins (18).
58
The Bcl-2 protein family consists of both anti-and pro-apoptotic members that form a 59 critical decision point within a common cell-death signaling pathway (18). The delicate balance 60 between anti-and pro-apoptotic protein activities dictates whether a cell will succumb to an 61 apoptotic stimulus or not (1). Our current understanding of the canonical apoptosis mechanism 62 involves activation of the signaling transduction pathway by an external cell death stimulus. The 63 cell death signal gets transmitted through pro-apoptotic factors such as Bax and Bak that go on to 64 inflict mitochrondrial damage and cytochrome c release (21). Inhibition of apoptosis is mainly Bcl-2 antagonist of cell death (BAD), which specifically blocks the activity of both anti-68 apoptotic factors by forming heterodimeric complexes with either of the two proteins and 69 displacing Bax (38, 40) .
70
Apoptosis has long been considered a host cell defence response because various pathogenic 71 viruses express anti-apoptotic proteins to prevent this cellular response (23). However, there is 72 now accumulating evidence to strongly suggest a number of viruses may manipulate the cell 73 death signaling pathway to promote viral replication, including influenza viruses (20, 22, 26, 27, 74 29, 30, 32, 36, 37) . Influenza virus infection resulted in the up-regulation of pro-apoptotic factors were observed with siRNA-treated cells (Fig. 1 B) . This lack of CPE development in virus- KD was confirmed by qRT-PCR for both shRNA and siRNA treatments (Fig. 2 A, B) . Western 236 blots for endogenous BAD protein supports the real-time PCR results (Fig. 2 C, D) . BAD protein 237 was significantly reduced for both shRNA species (Fig. 2 C) as well as for all 4 siRNA 238 oligomers tested (Fig. 2 D) . Treatment of A549 cells with shRNA or siRNA alone did not affect 239 cell viability as determined by the WST-1 cell proliferation assay (Fig. 2 E, F stable BAD KD and non-targeting shRNA A549 cells were infected with NY55, and virus 254 replication was followed over a 72 h period. Virus progeny yield was also determined for PR8 255 and SOIV. Virus progeny production was titered by plaque assay on MDCK cells.
256
The initial rounds of virus replication in shRNA BAD KD cells and shRNA non-targeting 257 control (shNSi) cells from 0 hpi to 12 hpi were comparable (Fig. 3A) . However, subsequent 258 viral replication after 12 hpi was less efficient in BAD KD cells compared to the control cells 259 (Fig. 3 A) . NY55 production was significantly reduced to less than 37% and 15% of the non- 
264
To ensure that a reduction in viral replication was not due to the effect of shRNA and/or 265 lentivirus treatment, we repeated the infections in siRNA transiently transfected A549 cells.
Cells were sequentially treated twice with each of four distinct siRNAs that target BAD (plus a 267 non-targeting siRNA control) 24 h apart, and after a further 24 h, were infected with NY55, PR8,
268
or SOIV influenza viruses. Virus titer was determined at 72 hpi.
269
Replication of all three virus strains was dramatically reduced in siRNA BAD KD cells (Fig.   270 3 C, E). NY55 production was reduced to less than 24% of the non-targeting control by all four 271 siRNA species (Fig. 3 C , P < 0.001). SOIV and PR8 titers were less than 10% and 11% of the 272 controls, respectively; this was slightly lower than that detected for NY55 titer, which was ~
273
19% of the control ( NY55. Viral protein production was determined at specific time points over a 72 h period. The 286 membrane was probed for influenza virus proteins NS1, NP, and HA. The NS1 mouse 287 monoclonal antibody was generated and characterized in our lab (Rahim et al., submitted) , and 288 the characterization of the mouse monoclonal NP antibody was previously described (39). In the stably expressing non-targeting shRNA control cells, NS1, NP, and HA viral proteins were 290 detected as early as 4 hpi, and strongly detected at 8 hpi onwards (Fig. 4A, left column) . Protein 291 bands were faintly detected as early as 0 hpi for the HA viral protein. Since HA is incorporated 292 into virion particles, the early detection could be due to the infecting viral population initially 293 introduced. In contrast, the production of all three viral proteins were clearly reduced in infected 294 BAD KD cells (Fig. 4A, right column) . Densitometric analysis of the viral protein bands showed 295 an average of 5-fold and 4-fold reduction of NP and HA protein, respectively, in BAD KD cells 296 compared to the non-targeting (shNSi) shRNA control (Fig. 4 B, D) . NS1 protein production 297 between BAD KD cells and non-targeting shRNA control is comparable from 8 hpi to 22 hpi but 298 NS1 protein level dramatically dipped lower in BAD KD cells between 24 -72 hpi, with an 299 average of 3-fold reduction in BAD KD cells (Fig. 4 C) . The results suggest that BAD KD 300 significantly reduces the efficiency of viral replication.
302
Influenza virus induces phosphorylation and cleavage of BAD. BAD's capacity to bind and 303 neutralize anti-apoptotic proteins is inhibited upon phosphorylation (6). Given that our results
304
showed BAD as a valuable cellular factor required for influenza virus replication, we suspected 305 that viral replication might affect BAD activity and how BAD is regulated. We infected A549 306 cells with NY55 and harvested samples at specific time points post-infection. The samples were 307 subjected to Western blot analysis and probed for BAD phosphorylation at sites S112 and S136.
308
Total BAD was also determined.
309
Our results showed that influenza virus infection induces BAD phosphorylation at both 310 S112 and S136 but in a sequential manner (Fig. 5) . Phosphorylation at S112 occurred as early as 311 14 hpi, with most intense bands observed at 20-22 hpi, and was gradually reduced after 24 hpi. (Fig. 5) .
316
All these modifications observed during influenza virus infection were not detected in uninfected 317 (mock) controls. Our results suggest that influenza viruses tightly control BAD activity via 318 phosphorylation and cleavage to regulate the intrinsic apoptotic signaling cascade. 
329
We observed an increase in the release of cytochrome c into the cytosol of infected non-330 targeting control at 20 hpi to 48 hpi relative to the uninfected (mock) samples (Fig. 6, row 1) . As 331 expected, the corresponding mitochondrial pellet of the infected non-targeting control showed a 332 decrease in cytochrome c at 20 hpi to 48 hpi (Fig. 6, row 5) . We did not observe a similar 333 increase in cytochrome c release into the cytosol of infected BAD KD cells (Fig. 6, row 2) , and (Fig. 6, row 6 ). These data suggest that influenza viruses induce 
BAD is required for efficient induction of caspase activity after influenza virus infection.
341
Influenza virus infection results in the activation of apoptosis both in vivo and in vitro (28, 34).
342
We determined caspase activity in BAD KD A549 cells infected with NY55 at an MOI of 1.
343
Caspase activity was measured at 72 hpi using the Promega Caspase-Glo 3/7 kit. Non-transduced (Fig. 7 B, left column) . However, caspase-3 cleavage was undetected at time points 363 before 72 hpi and significantly reduced cleaved caspase-3 was detected in the infected BAD KD 364 lane at 72 hpi (Fig. 7 B, right column) .
365
We also observed caspase-7 cleavage in the infected non-targeting control, with significant 366 cleavage occurring between 30 -72 hpi (Fig. 8 A, left column) . Similar to our observation with 367 caspase-3, cleavage of caspase-7 was suppressed in BAD KD cells compared to the non-368 targeting control (Fig. 8 A, right column) . Densitometric analysis of cleaved caspase-7 in the 369 infected lanes showed on average a 5-fold reduction in caspase-7 cleavage compared to the 370 shRNA non-targeting control cells (Fig. 8 B) . These results suggest that influenza viruses need 371 BAD in order to induce caspase activation.
372
Caspase-3 and -7 are effector caspases that cleave other proteins downstream of the 373 apoptotic signaling pathway. One of these downstream substrates is PARP. We looked at PARP 374 cleavage during influenza virus infection at specific time points late in the replication cycle in 375 both the non-targeting control and BAD KD cells. Our results showed that influenza virus 376 replication induces increasingly greater PARP cleavage from 14 hpi to 72 hpi (Fig. 8 A) .
377
However, cleaved PARP was only faintly detected in western blots of infected BAD KD cell 378 lysates. Densitometric analysis showed more than a 10-fold reduction of PARP cleaved in the 379 knockdown cells (Fig. 8 C) . Interestingly, greater caspase-7 and PARP cleavage in the non-380 targeting control corresponded with an elevated expression of NS1 (Fig. 4 and Fig. 8 ). The cleavage of both caspase-7 and PARP appeared most elevated at 30 hpi, suggesting this to be a 
Discussion
389
Influenza virus induces cell death through activation of the apoptotic pathway, a process 390 regarded as a major contributor to influenza virus pathogenesis that results in extensive lung 391 tissue damage (3, 22) . Blockage of the cell death pathway also leads to a significant decline in 392 virus production (26). We report here that influenza virus-induced apoptosis requires BAD.
393
Our results showed that influenza viruses failed to induce cytopathology and cell death in BAD's ability to associate and inhibit anti-apoptotic factors is regulated by phosphorylation 404 at three residues: S112, S136, and S155 (6). A tiered phosphorylation and model of BAD 405 inactivation has been proposed based on evidence that showed phosphorylation at S155 requires 406 priming phosphorylation on S136 and S112 residues (6, 8). Sites S136, and especially S155, are 407 reported to be more potent sites required for inactivating BAD activity (8, 24). Moreover, 408 complete BAD inactivation requires phosphorylation of at least two serine residues (8). We 409 determined that influenza viruses induce BAD phosphorylation of S112 and S136 sequentially 410 from mid to late viral replication cycle. S112 phosphorylation occurred before S136, and both 411 phosphorylation process gradually tapered off after 48 hpi. A study has shown that viral NS1 412 protein interacts with Akt, which results in enhanced Akt activity (25). S136 phosphorylation 413 occurs via Akt in the PI3K signalling pathway (7, 10). We noticed an increase in NS1 protein 414 production at 18 hpi to 20 hpi, whereas phosphorylation at S136 occurred from 20 hpi onward. Eventually, the death signaling factors will overwhelm the virus' control and cell death will 432 occur.
433
In the absence of BAD, we observed a suppression of cytochrome c release from the 434 mitochondria, which is an early process of the intrinsic apoptotic cascade. Cytochrome c release 435 will lead to the eventual downstream cleavage and activation of caspase-3 and caspase-7.
436
Although the specific role of caspase-7 during influenza replication remains uncertain, it has 437 been shown that caspase-3 cleavage is essential for influenza virus propagation (37). We show 
588
NSi is nontargeting shRNA or siRNA control. Shown is the mean from 3 independent replicates 589 with error bars representing standard deviation (* P < 0.001). 
